Insights into the molecular targets and emerging pharmacotherapeutic interventions for nonalcoholic fatty liver disease
{{output}}
Nonalcoholic fatty liver disease (NAFLD) is the most common form of chronic liver disease worldwide. With no Food and Drug Administration approved drugs, current treatment options include dietary restrictions and lifestyle modification. NAFLD is closely associ... ...
